249 related articles for article (PubMed ID: 12895609)
1. Use of self-expanding vascular endoprostheses in superior vena cava syndrome.
García Mónaco R; Bertoni H; Pallota G; Lastiri R; Varela M; Beveraggi EM; Vassallo BC
Eur J Cardiothorac Surg; 2003 Aug; 24(2):208-11. PubMed ID: 12895609
[TBL] [Abstract][Full Text] [Related]
2. The role of self-expanding vascular stent in superior vena cava syndrome for advanced tumours.
Irace L; Martinelli O; Gattuso R; Mingoli A; Fiori E; Alunno A; Di Girolamo A; Crocetti D; Sapienza P
Ann R Coll Surg Engl; 2021 Apr; 103(4):296-301. PubMed ID: 33682470
[TBL] [Abstract][Full Text] [Related]
3. Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause.
Büstgens FA; Loose R; Ficker JH; Wucherer M; Uder M; Adamus R
Rofo; 2017 May; 189(5):423-430. PubMed ID: 28152555
[No Abstract] [Full Text] [Related]
4. Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancer.
Calsina Juscafresa L; Gil Bazo I; Grochowicz L; Páramo Alfaro M; López-Picazo González JM; Moreno Jiménez M; Bilbao Jaureguizar JI
Hosp Pract (1995); 2017 Aug; 45(3):70-75. PubMed ID: 28618844
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous treatment of superior vena cava syndrome using metallic stents.
de Gregorio Ariza MA; Gamboa P; Gimeno MJ; Alfonso E; Mainar A; Medrano J; López-Marin P; Tobio R; Herrera M
Eur Radiol; 2003 Apr; 13(4):853-62. PubMed ID: 12664126
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous stenting of superior vena cava syndrome: treatment outcome in patients with benign and malignant etiology.
Barshes NR; Annambhotla S; El Sayed HF; Huynh TT; Kougias P; Dardik A; Lin PH
Vascular; 2007; 15(5):314-21. PubMed ID: 17976332
[TBL] [Abstract][Full Text] [Related]
7. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava.
Nagata T; Makutani S; Uchida H; Kichikawa K; Maeda M; Yoshioka T; Anai H; Sakaguchi H; Yoshimura H
Cardiovasc Intervent Radiol; 2007; 30(5):959-67. PubMed ID: 17546400
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous stenting of superior vena cava syndrome: a case report and review of the literature.
Hochrein J; Bashore TM; O'Laughlin MP; Harrison JK
Am J Med; 1998 Jan; 104(1):78-84. PubMed ID: 9528723
[TBL] [Abstract][Full Text] [Related]
9. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome.
Lanciego C; Pangua C; Chacón JI; Velasco J; Boy RC; Viana A; Cerezo S; García LG
AJR Am J Roentgenol; 2009 Aug; 193(2):549-58. PubMed ID: 19620456
[TBL] [Abstract][Full Text] [Related]
10. Sequential treatment of superior vena cava syndrome caused by of non-small cell carcinoma lung cancer (NSCLC) with vascular stenting and iodine-125 implantation.
Xiao L; Li Z; Wu L; Sun Z; Yu X
Technol Cancer Res Treat; 2009 Aug; 8(4):281-7. PubMed ID: 19645521
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes : long-term follow-up.
Breault S; Doenz F; Jouannic AM; Qanadli SD
Eur Radiol; 2017 Jan; 27(1):97-104. PubMed ID: 27085696
[TBL] [Abstract][Full Text] [Related]
12. [Superior vena cava thrombosis or stricture secondary to implanted central venous access: Six cases of endovascular and direct surgical treatment in cancer patients].
Fichelle JM; Baissas V; Salvi S; Fabiani JN
J Med Vasc; 2018 Feb; 43(1):20-28. PubMed ID: 29425537
[TBL] [Abstract][Full Text] [Related]
13. A Review of Open and Endovascular Treatment of Superior Vena Cava Syndrome of Benign Aetiology.
Sfyroeras GS; Antonopoulos CN; Mantas G; Moulakakis KG; Kakisis JD; Brountzos E; Lattimer CR; Geroulakos G
Eur J Vasc Endovasc Surg; 2017 Feb; 53(2):238-254. PubMed ID: 28007450
[TBL] [Abstract][Full Text] [Related]
14. Endovascular treatment of stenoses in the superior vena cava syndrome caused by non-tumoral lesions.
Bornak A; Wicky S; Ris HB; Probst H; Milesi I; Corpataux JM
Eur Radiol; 2003 May; 13(5):950-6. PubMed ID: 12695814
[TBL] [Abstract][Full Text] [Related]
15. Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy.
Fagedet D; Thony F; Timsit JF; Rodiere M; Monnin-Bares V; Ferretti GR; Vesin A; Moro-Sibilot D
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):140-9. PubMed ID: 22146975
[TBL] [Abstract][Full Text] [Related]
16. Benign superior vena cava syndrome: stenting is now the first line of treatment.
Rizvi AZ; Kalra M; Bjarnason H; Bower TC; Schleck C; Gloviczki P
J Vasc Surg; 2008 Feb; 47(2):372-80. PubMed ID: 18241760
[TBL] [Abstract][Full Text] [Related]
17. Subacute and chronic benign superior vena cava obstructions: endovascular treatment with self-expanding metallic stents.
Qanadli SD; El Hajjam M; Mignon F; de Kerviler E; Rocha P; Barré O; Chagnon S; Lacombe P
AJR Am J Roentgenol; 1999 Jul; 173(1):159-64. PubMed ID: 10397119
[TBL] [Abstract][Full Text] [Related]
18. Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease.
Kalra M; Gloviczki P; Andrews JC; Cherry KJ; Bower TC; Panneton JM; Bjarnason H; Noel AA; Schleck C; Harmsen WS; Canton LG; Pairolero PC
J Vasc Surg; 2003 Aug; 38(2):215-23. PubMed ID: 12891100
[TBL] [Abstract][Full Text] [Related]
19. Endovascular stent-based revascularization of malignant superior vena cava syndrome with concomitant implantation of a port device using a dual venous approach.
Anton S; Oechtering T; Stahlberg E; Jacob F; Kleemann M; Barkhausen J; Goltz JP
Support Care Cancer; 2018 Jun; 26(6):1881-1888. PubMed ID: 29274029
[TBL] [Abstract][Full Text] [Related]
20. [Stenting for superior vena cava obstruction associated with lung cancer: monocentric study].
Pierre MC; Chabbert V; Lozano S; Bigay-Game L; Lévêque N; Desloques L; Otal P; Rousseau H; Didier A; Mazières J
Rev Mal Respir; 2009 Sep; 26(7):744-50. PubMed ID: 19953016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
